Glenmark Pharmaceuticals informs about outcome of board meeting

29 May 2021 Evaluate

Glenmark Pharmaceuticals has informed that the Board of Directors of at its meeting held on May 28, 2021, which commenced at 05.30 pm and concluded at 09:55 pm, considered and approved the following: Audited Financial Results for the year ended March 31, 2021. Pursuant to regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has enclosed the said results together with Management Discussion & Analysis, Press Release, Investor Presentation, Auditors Report and Declaration of unmodified opinion. These are also being made available on the website of the Company at www.glenmarkpharma.com and Recommended Dividend @ 250% Rs 2.50 per share (face value of Re 1 each) on the Equity Share Capital of the Company for the financial year 2020-21 subject to the approval of the Shareholders at the ensuing Annual General Meeting.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1974.05 17.65 (0.90%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×